Exosome Therapy in Orthopedics: What Does the Evidence Show?

Exosome Therapy in Orthopedics: What Does the Evidence Show?

What is exosome therapy and does it work for knees and joints? Where the evidence stands today, how it differs from PRP and stem cells, the possible risks and questions to ask before deciding.

Exosome therapy involves injecting tiny vesicles released by cells into a joint or tendon, and in orthopedics it is still at the research stage. Laboratory and animal studies have produced encouraging signals, but large, well-designed clinical trials showing that exosomes work and are safe in the long term for knee osteoarthritis, cartilage damage or tendon problems in people are still lacking. For now, exosome injections should be seen as an option with limited evidence and no agreed standard, not as a routine treatment.

This article explains what exosomes are, why they attract interest in orthopedics, where the evidence currently stands, how they differ from PRP and stem cell treatments, what the risks are, and which questions to ask if you are offered this treatment.

What are exosomes?

Exosomes are microscopic, membrane-bound vesicles released by almost every cell in the body. Scientists group them under the wider term "extracellular vesicles". They carry proteins, lipids and regulatory molecules such as microRNA, and act as messengers that influence the behavior of neighboring cells.

Exosomes are not living cells: they do not divide, multiply or settle into tissue to build new tissue. Products used in orthopedics are usually derived from the secretions of laboratory-grown mesenchymal stem cells, cells from placental or umbilical tissue, or platelets. Their source, processing method and purity vary widely from one product to another.

Why the interest in orthopedics?

Research on stem cell treatments suggested that much of their effect may come not from the cells turning into new tissue but from the signaling molecules they release. Exosomes are thought to be one of the carriers of those signals, and because they contain no cells, they may offer some practical advantages in storage and handling.

Laboratory and animal research has reported effects such as:

• Signals that may help dampen inflammation inside the joint
• Findings suggesting slower breakdown of cartilage cells
• Cellular responses that might support tendon and ligament healing
• Possible benefits for bone healing and blood vessel formation

However, most of these findings come from cell cultures and animal models. Whether an effect seen in the lab translates into meaningful clinical results in people, such as less pain or better joint function, has to be proven separately. Many approaches that looked promising in the laboratory have not lived up to expectations in human studies.

What does the evidence say today?

To put it plainly, there are few human studies of exosomes for orthopedic conditions, and most are small, short-term, early-phase safety studies. Randomized controlled trials comparing exosomes with placebo or established treatments, in enough patients and over a long enough period, are still lacking for knee osteoarthritis, cartilage injury or tendon problems.

The main reasons the evidence remains limited are:

• No standardization: products differ in source, isolation method, particle content and purity, so two "exosome" products can be very different.
• Unknown dosing: how much should be injected, how often and at what intervals is not established.
• No long-term data: effects and possible side effects over years are not known.
• Regulation: the US Food and Drug Administration (FDA) has stated that no exosome product is approved for orthopedic use and has warned the public after reports of serious adverse events linked to unapproved products.

None of this means exosomes will never be useful. It means that, today, they are not a treatment with proven effectiveness and safety for routine use. Properly conducted clinical research will answer these questions over time.

Exosomes vs PRP vs stem cells

• PRP (platelet-rich plasma): prepared from your own blood. It has been studied more than the other two in knee osteoarthritis and some tendon problems, although results vary between studies and preparation methods are not standardized. See our article on the scientific basis of PRP.
• Stem cell treatments: usually cell-containing preparations taken from your own bone marrow or fat. Clinical data are growing, but which patients benefit, and how much, is still debated. Realistic expectations are covered in is joint regeneration possible with stem cells?
• Exosomes: contain no cells and are usually made from the secretions of laboratory-grown cells from other sources. Of the three, they have the fewest human studies in orthopedics.

Newer does not automatically mean more effective. A treatment's value is measured by the benefit and safety shown in well-designed studies.

Risks and things to watch out for

As with any joint injection, there is a risk of pain and swelling at the injection site and, rarely, infection. With products made outside recognized standards, additional concerns include contamination, contents that differ from the label and immune reactions. Long-term effects on tissues are not yet well understood.

Online reviews from people who have had exosome injections reflect personal experiences and do not show whether a treatment works. Knee pain naturally fluctuates, and only controlled studies can separate the effect of a treatment from natural improvement or expectation. Likewise, price comparisons say little about value, because products are not standardized and their contents can differ widely.

Questions to ask if you are offered exosomes

1. Where does the product come from, who makes it and what is its regulatory status?
2. Are there human studies showing benefit for my specific condition?
3. Is this being given as part of a clinical trial?
4. What are the possible side effects, and how will I be followed up?
5. Which better-established treatments are available, and have I tried them?

Which treatments are better understood?

For knee and hip osteoarthritis, cartilage problems and tendon injuries, treatment usually starts with better-established steps: exercise and physiotherapy, weight management, activity changes, appropriate medication and, when needed, joint injections. If there is a structural problem, arthroscopic procedures, osteotomy or joint replacement may be considered. The right step depends on symptoms, age, activity level and imaging. For our approach to biological treatments and when they may be considered, see our cellular therapies (PRP, stem cell) page.

When should you see an orthopedic surgeon?

Before deciding on a new treatment such as exosomes, the most important step is an accurate diagnosis. Consider seeing an orthopedic surgeon if you have:

• Joint pain lasting several weeks that does not improve with home measures
• Recurrent knee swelling, locking or giving way
• Night pain or pain that does not settle with rest
• A clear drop in walking distance or difficulty with stairs
• Been offered a new injection treatment and want a second opinion

Urgent: increasing pain, redness, warmth and swelling with fever in the days after any injection may signal a joint infection and needs prompt assessment.

At Prof. Dr. Gökhan Polat's clinic, treatment options are discussed openly with each patient, including the diagnosis, the strength of the evidence, possible benefits and risks. As with any treatment, response varies from person to person.

Summary

• Exosomes are tiny vesicles released by cells that play a role in cell-to-cell communication; they contain no living cells.
• Most promising findings in orthopedics come from laboratory and animal research; human evidence is currently limited.
• Products are not standardized, and dosing, content and long-term safety remain uncertain.
• Get a clear diagnosis and discuss better-established options with your doctor before deciding.

This article is for general information only; diagnosis and treatment decisions are made individually after examination and the necessary tests.